Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

962
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
962
Seizures: Classification01:13

Seizures: Classification

1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

732
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
732
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.0K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)cinnamamides as Potential Covalent Inhibitors for Oncology.

Chemical biology & drug design·2025
Same author

Investigating the protective effects of luteolin and gallic acid from Luffa acutangulavar. amara (Roxb.) C. B. Clarke. Fruit pericarp against alcohol-induced liver toxicity: Extraction, bioactivity-guided fractionation, molecular docking, and dynamics studies.

Journal of ethnopharmacology·2025
Same author

Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics.

Drug development research·2023
Same author

Phytochemical profile, antioxidant, cytotoxic and anti-inflammatory activities of stem bark extract and fractions of <i>Ailanthus excelsa</i> Roxb.: <i>In vitro, in vivo</i> and <i>in silico</i> approaches.

Heliyon·2023
Same author

S-BIRD: A Novel Critical Multi-Class Imagery Dataset for Sewer Monitoring and Maintenance Systems.

Sensors (Basel, Switzerland)·2023
Same author

Chemical composition and biological activities of <i>Lonicera caprifolium</i> L. (Caprifoliaceae) essential oil.

Natural product research·2023

Related Experiment Video

Updated: Feb 18, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.5K

ISATIN: New Hope Against Convulsion.

Rameshwar S Cheke1, Sandip D Firke1, Ravindra R Patil1

  • 1Department of Pharmaceutical Chemistry, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule, 425405 Maharashtra, India.

Central Nervous System Agents in Medicinal Chemistry
|November 17, 2017
PubMed
Summary

Isatin derivatives show promise as novel anticonvulsant drugs for epilepsy treatment, offering potential alternatives to existing medications with fewer side effects. Further research into isatin-based compounds could lead to more effective epilepsy therapies.

Keywords:
AnticonvulsantMESdockingepilepsyisatinsc-PTZ.

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.4K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.3K

Related Experiment Videos

Last Updated: Feb 18, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.5K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.4K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.3K

Area of Science:

  • * Medicinal Chemistry
  • * Organic Chemistry
  • * Pharmacology

Background:

  • * Epilepsy is a significant global neurological disorder with unmet treatment needs.
  • * Current antiepileptic drugs often have adverse effects and drug interactions.
  • * There is a continuous demand for novel and safer anticonvulsant agents.

Purpose of the Study:

  • * To explore isatin derivatives as potential anticonvulsant agents.
  • * To review synthetic strategies for designing isatin-based anticonvulsants.
  • * To identify key structural features for enhanced anticonvulsant activity.

Main Methods:

  • * Comprehensive literature search for isatin derivatives with anticonvulsant properties.
  • * Analysis of synthetic pathways for isatin compound development.
  • * Review of various anticonvulsant evaluation tests and their outcomes.

Main Results:

  • * Established synthetic schemes for designing isatin derivatives as anticonvulsant agents.
  • * Identified critical structural elements for optimizing isatin compound efficacy.
  • * Documented anticonvulsant activities evaluated through diverse pharmacological tests.

Conclusions:

  • * Isatin serves as a versatile scaffold for developing compounds with biological activities.
  • * Modifications at N1, C2, C3, and the aromatic ring offer extensive synthetic possibilities.
  • * Novel isatin derivatives, including hybrid molecules, are continuously being investigated for targeted epilepsy treatment.